Non-Covalent Dimer Cations for Cell Repair and Wound Healing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cell damage and wound healing focus on targeted disease management, neglecting the cell's self-repair ability, leading to slow progress and side effects, while elderly individuals and those with weak tissue cell proliferation face increased disease risk and slow wound healing.

Innovation Solution

A non-covalent dimer cation composed of purine/pyrimidine derivatives and amino acids, or their salts, is used to prepare medicaments that promote cell proliferation and reduce oxidative stress, enhancing the body's natural repair mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If targeted treatment of diseases is focused upon, then disease management is improved, but cell self-repair ability is neglected leading to slow progress and side effects

Engineering Contradiction:
Improvedisease management effectivenessVSAvoidtreatment progress
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent activates the cell's inherent self-repair mechanisms through non-covalent dimer cations that modulate cellular pathways, enabling cells to repair themselves rather than relying on external targeted interventions. This approach leverages the body's natural repair capabilities to treat diseases while avoiding the side effects of aggressive targeted therapies.

Inventive Principle:
Principle #25Self-service

2Reliability

If targeted treatment of diseases is focused upon, then disease management is improved, but side effects occur due to neglecting cell self-repair ability

Engineering Contradiction:
Improvedisease management effectivenessVSAvoiddrug side effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The compound enables cells to perform their own repair functions, eliminating the need for external drugs that cause side effects. The non-covalent dimer cation acts as a mild modulator that triggers endogenous repair pathways without the harsh effects of conventional targeted therapies.

Inventive Principle:
Principle #25Self-service

3Reliability

If elderly individuals and those with weak tissue cell proliferation are treated conventionally, then disease management is attempted, but wound healing is slow and disease risk increases

Engineering Contradiction:
Improvedisease managementVSAvoidwound healing speed
Core Design Contradiction:
ReliabilityVSSpeed

Solution Approach 1:

The non-covalent dimer cation alters key cellular parameters including ROS levels, inflammatory responses, and proliferation signals to create an optimal environment for wound healing. This parameter modulation accelerates the healing process in elderly and immunocompromised individuals who would otherwise heal slowly.

Inventive Principle:
Principle #35Parameter changes

4Object-affected harmful factors

If intracellular ROS level is reduced directly, then oxidative stress is addressed, but cell repair ability is not restored effectively

Engineering Contradiction:
Improveoxidative stressVSAvoidcell repair ability restoration
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The non-covalent dimer cation serves as an intermediary that indirectly reduces ROS levels by activating cellular antioxidant pathways and improving overall cell function. Rather than directly scavenging ROS, the compound mediates a cascade of events that naturally lowers oxidative stress while simultaneously enhancing repair capabilities.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentEP4692087A1Non-covalent dimer cation of purine/pyrimidine and amino acid, salt thereof, preparation method therefor, and use thereof
Publication Date: 2026.02.11 SUZHOU PROTONATION CHAIN BIOTECHNOLOGY CO LTD
  • EP4692087A1 patent drawing
  • EP4692087A1 patent drawing
  • EP4692087A1 patent drawing

AI summary

Provided is a non-covalent dimer cation of the present application, comprising or consisting of a cation of formula [+Q1-H···Q2], a tautomer thereof, or a stereoisomer thereof. Provided is a salt of the present application, including the cation of the present application and a first anion. Provided is use of the cation of the present application or the salt of the present application, for example, use in the preparation of a medicament for promoting cell repair, cell proliferation, or wound repair.